![]() |
市场调查报告书
商品编码
1462745
2030 年医疗保健布料市场预测:按布料类型、材料、应用、最终用户和地区进行的全球分析Healthcare Fabrics Market Forecasts to 2030 - Global Analysis By Fabric Type, Raw Material, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球医疗保健布料市场规模为 197 亿美元,预计在预测期内将以 9.2% 的复合年增长率增长,到 2030 年达到 365 亿美元。
医疗保健织物是专为医疗和保健应用而设计的专用纺织品,其设计符合严格的卫生、耐用性和舒适性标准,包括耐液体性、透气性和易于消毒,具有以下特性。医疗保健材料在保持清洁、预防感染以及促进医疗环境中患者和医护人员的安全方面发挥着至关重要的作用。
根据美国医院协会统计,美国有超过 1.33 亿人(近一半人口)患有至少一种慢性病。
更加重视患者舒适度
随着医疗保健组织努力提供以患者为中心的护理,人们越来越认识到纺织品在促进舒适、尊严和福祉方面所发挥的作用。患者舒适度影响满意度、治疗结果,甚至患者对护理通讯协定的依从性,被认为是优质医疗服务的关键组成部分。此外,根据这些患者的具体需求和偏好量身定制医疗保健布料将进一步推动创新和市场需求。
经济不确定性
由于经济低迷,政府和医疗机构可能面临预算限制和医疗成本降低,导致实施成本削减措施并影响医疗保健织物的采购。此外,经济不确定性可能会扰乱全球供应链,影响製造医疗保健织物所需原材料的采购和供应,并阻碍市场成长。
严格的卫生标准
随着病患安全和感染预防成为医疗保健的首要任务,对具有卓越抗菌性能、耐液体性和易于消毒的医疗保健织物的需求不断增长。此外,法规和认证标准要求医疗机构遵守严格的环境健康准则。这些标准要求使用高品质的医疗保健布料,这些布料能够承受频繁的洗涤、消毒和灭菌处理,而不会影响性能或耐用性,这正在推动市场成长。
有限采用先进技术
儘管纺织品製造的技术创新取得了进步,但这些技术在医疗保健环境中的采用率仍然有限。采用有限的主要原因之一是医疗保健专业人员缺乏对先进医疗保健纺织品的好处和功能的认识和教育。此外,医疗保健决策者可能不熟悉最新的纺织品创新,或发现它们复杂且难以整合到现有的工作流程中,这可能会阻碍市场成长。
COVID-19 的影响
COVID-19 大流行对医疗保健纺织品市场产生了一些负面影响,扰乱了供应链,改变了需求动态,并导致经济不稳定。这种中断导致生产和分销延迟,影响了医疗保健织物的可用性并增加了製造商的前置作业时间。此外,许多医疗机构面临财务限制,限制了其投资新纺织品或升级现有基础设施的能力,从而阻碍了市场扩张。
预计聚酰胺细分市场在预测期内将是最大的
由于其多功能特性和在医用纺织品中的广泛应用,预计聚酰胺细分市场将占据最大份额。这些织物具有优异的耐磨性、撕裂强度和尺寸稳定性,使其成为手术服、手术单、伤口敷料等的理想选择。此外,基于聚酰胺的织物可以提供水分管理特性,提高穿着者在长时间使用期间的舒适度,从而推动该领域的成长。
私人诊所产业预计在预测期内复合年增长率最高
独立经营诊所预计在预测期内复合年增长率最高,因为它们拥有独立所有权并专注于个人化护理。我们也经常优先使用高品质材料来改善患者体验并使我们的服务与众不同。此外,私人诊所通常会优先考虑医疗保健织物的客製化选项,这些选项可以根据诊所的品牌和美学偏好进行定制,从而推动该领域的成长。
由于卫生标准意识不断提高以及新兴经济体医疗基础设施的扩张,亚太地区在预测期内占据了最大的市场占有率。中国、印度和日本等国家的政府正在大力投资发展医院、诊所和门诊病人设施等医疗基础设施,这推动了医用纺织品的需求,并扩大了该地区的市场规模。
由于人口成长、都市化和人口老化导致医疗保健需求和设施增加,预计欧洲在预测期内将出现最高的复合年增长率。该地区的主要企业包括 Avgol Industries 1953 Ltd.、Freudenberg Group 和 Berry Global Group Inc.。此外,与当地公司的合作以及研发投资进一步促进了该地区的创新和产品多元化。
According to Stratistics MRC, the Global Healthcare Fabrics Market is accounted for $19.7 billion in 2023 and is expected to reach $36.5 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Healthcare fabrics are specialized textiles designed for medical and healthcare applications, engineered to meet stringent standards of hygiene, durability, and comfort, they offer features such as fluid resistance, breathability, and ease of sterilization. Healthcare fabrics play a crucial role in maintaining cleanliness, preventing infections, and promoting patient and healthcare worker safety within medical environments.
According to the American Hospital Association, more than 133 million people in the U.S., nearly half the population, suffer from at least one chronic illness.
Increasing focus on patient comfort
As healthcare institutions strive to deliver patient-centered care, there is growing recognition of the role that textiles play in promoting comfort, dignity, and well-being. Patient comfort is recognized as a crucial component of quality healthcare delivery, influencing satisfaction levels, treatment outcomes, and even patient adherence to care protocols. Moreover, tailoring healthcare fabrics to meet the specific needs and preferences of these populations' further drives innovation and market demand.
Economic uncertainty
Governments and healthcare institutions may face budget constraints and cutbacks in healthcare funding due to a weaker economy, which in turn affects the procurement of healthcare fabrics as cost-cutting measures are implemented. Furthermore, economic uncertainty can disrupt global supply chains, affecting the sourcing and availability of raw materials necessary for manufacturing healthcare fabrics, thereby impeding market growth.
Stringent hygiene standards
With patient safety and infection prevention at the forefront of healthcare priorities, there is a growing demand for healthcare fabrics that offer superior antimicrobial properties, fluid resistance, and easy sterilization capabilities. Furthermore, regulatory mandates and accreditation standards compel healthcare facilities to adhere to strict guidelines for environmental hygiene. These standards necessitate the use of high-quality healthcare fabrics that can withstand frequent laundering, disinfection, and sterilization processes without compromising performance or durability, which is fostering market growth.
Limited adoption of advanced technologies
Despite ongoing innovations in textile manufacturing, adoption rates of these technologies remain constrained within healthcare settings. One primary reason for this limited adoption is the lack of awareness and education among healthcare professionals regarding the benefits and capabilities of advanced healthcare fabrics. Furthermore, healthcare decision-makers may be unfamiliar with the latest textile innovations or may perceive them as complex and challenging to integrate into existing workflows, which gradually hinders the market size.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the healthcare fabrics market, disrupting supply chains, altering demand dynamics, and causing economic uncertainty. This disruption led to delays in production and distribution, affecting the availability of healthcare fabrics and increasing lead times for manufacturers. In addition, many healthcare facilities faced financial constraints, limiting their ability to invest in new textiles or upgrade existing infrastructure, thereby impeding this market expansion.
The polyamide segment is expected to be the largest during the forecast period
The polyamide segment is estimated to hold the largest share, due to its versatile properties and wide range of applications in medical textiles. These fabrics offer excellent abrasion resistance, tear strength, and dimensional stability, making them ideal for surgical gowns, drapes, and wound dressings. Additionally, polyamide-based fabrics can be engineered to provide moisture management properties, enhancing wearer comfort during prolonged uses, which is boosting this segment's growth.
The private clinics segment is expected to have the highest CAGR during the forecast period
The private clinics segment is anticipated to have highest CAGR during the forecast period due to their independent ownership and focus on personalized care. They often prioritize the use of high-quality fabrics to enhance the patient experience and differentiate their services. Furthermore, private clinics often prioritize customization options for healthcare fabrics, allowing them to align with the clinic's branding and aesthetic preferences, which are propelling this segment's expansion.
Asia Pacific commanded the largest market share during the extrapolated period owing to rising awareness of hygiene standards, and the expansion of healthcare infrastructure across emerging economies. Governments in countries like China, India, and Japan are investing heavily in healthcare infrastructure development, including hospitals, clinics, and outpatient facilities, which in turn fuels the demand for medical textiles, which significantly drives this region's size.
Europe is expected to witness highest CAGR over the projection period, owing to a growing population, urbanization, and an aging demographic, leading to greater healthcare needs and the proliferation of healthcare facilities. This region is home to some of the key players, such as Avgol Industries 1953 Ltd., Freudenberg Group, and Berry Global Group Inc. Moreover, collaboration with local players and investment in research and development further drive innovation and product diversification in this region.
Key players in the market
Some of the key players in the Healthcare Fabrics Market include Berry Global Group Inc., Asahi Kasei Corporation, Kimberly-Clark Corporation, Eximus Corporation, Carnegie Fabrics LLC, Freudenberg Group, Paramount Tech Fab Industries, Avgol Industries 1953 Ltd., Ahlstrom Munksjo OYJ and Knoll Inc.
In January 2024, EVANSVILLE and Berry Global Group, Inc announced that its wholly-owned subsidiary, Berry Global, Inc., plans to issue a new series of first priority senior secured notes.
In November 2022, Berry Global Group, Inc. a leading supplier of packaging solutions for consumer goods and industrial products, announced the appointments of three new independent members of the Company's Board of Directors (the "Board") and the formation of a Capital Allocation Committee.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.